PitchSend

Investor Presentaiton

ANDA¹ Portfolio & Pipeline (As on 30th June 2018) Total 25 152 + + 76 ANDA Portfolio Cipla 253 ANDAS 160 140 37 120 100 53 53 80 60 a 40 20 53 53 20 Approved ANDAS 1 Does not include Vet product ANDAS 4 Tentatively Approved ANDAS 2 ■Cipla Ltd PEPFAR Invagen 2 PEPFAR approved ANDAS can be commercialised in US Investor Presentation: Q1FY19 08-08-2018 622 21 47 Under Approval ANDAS Partnered ANDAS 8

View entire presentation